Welcome to LookChem.com Sign In|Join Free

CAS

  • or

671816-04-9

Post Buying Request

671816-04-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (1R)-trans-4-[N-Boc-1-aminoethyl]-N-4-pyridinyl-cyclohexanecarboxamide

    Cas No: 671816-04-9

  • No Data

  • No Data

  • No Data

  • BOC Sciences
  • Contact Supplier

671816-04-9 Usage

Description

(1R)-trans-4-[N-Boc-1-aminoethyl]-N-4-pyridinyl-cyclohexanecarboxamide is a complex organic compound with a unique molecular structure. It is characterized by its off-white solid appearance and is known for its protective properties towards Y-27632, a Rho kinase inhibitor (ROCK). (1R)-trans-4-[N-Boc-1-aminoethyl]-N-4-pyridinyl-cyclohexanecarboxamide is particularly useful in the treatment of ischemia-reperfusion disorders, showcasing its potential in the pharmaceutical industry.

Uses

Used in Pharmaceutical Applications:
(1R)-trans-4-[N-Boc-1-aminoethyl]-N-4-pyridinyl-cyclohexanecarboxamide is used as a protective agent for Y-27632, a Rho kinase inhibitor (ROCK), for the treatment of ischemia-reperfusion disorders. Its protective properties help maintain the stability and efficacy of Y-27632, making it a valuable component in the development of therapeutic strategies for such disorders.
Used in Chemical Research:
In the field of chemical research, (1R)-trans-4-[N-Boc-1-aminoethyl]-N-4-pyridinyl-cyclohexanecarboxamide serves as a valuable compound for studying its unique molecular structure and properties. Its off-white solid appearance and complex structure make it an interesting subject for further investigation and potential development of new applications in various industries.
Used in Drug Delivery Systems:
Similar to gallotannin, (1R)-trans-4-[N-Boc-1-aminoethyl]-N-4-pyridinyl-cyclohexanecarboxamide could potentially be utilized in drug delivery systems. Its protective properties towards Y-27632 may allow for the development of novel drug delivery systems that enhance the compound's delivery, bioavailability, and therapeutic outcomes, particularly in the treatment of ischemia-reperfusion disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 671816-04-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,1,8,1 and 6 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 671816-04:
(8*6)+(7*7)+(6*1)+(5*8)+(4*1)+(3*6)+(2*0)+(1*4)=169
169 % 10 = 9
So 671816-04-9 is a valid CAS Registry Number.

671816-04-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-[(1R)-1-[4-(pyridin-4-ylcarbamoyl)cyclohexyl]ethyl]carbamate

1.2 Other means of identification

Product number -
Other names (1R)-trans-4-[N-Boc-1-aminoethyl]-N-4-pyridinyl-cyclohexanecarboxamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:671816-04-9 SDS

671816-04-9Relevant articles and documents

A Rho kinase inhibitor Y27632 method for the preparation of compounds

-

, (2016/10/09)

The invention discloses a preparation method of a Rho kinase inhibitor Y27632 compound. Chirality of amine is constructed through a CBS reduction method high in selectivity to obtain amine with high optical purity, thus effectively and rapidly realizing s

1,4-SUBSTITUTED CYCLOHEXANE DERIVATIVES

-

Page 98; 99, (2010/02/06)

Allylic compounds represented by the formula (I) are provided, wherein each of R1 to R8, m, n, A and X are as defined in the Specification. These compounds can inhibit Rho kinase, and can find utility in repair of damaged nerves in the central and peripheral nervous system by inducing axon growth and regeneration, and in the treatment by inhibition of Rho kinase in disease states in which Rho kinase is implicated. The compounds are relatively cell permeable and pharmaceutical compositions thereof can promote neurite growth and are also useful for the prevention of cell proliferation in malignant deseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 671816-04-9